Weeden; Timothy

Patent Applications and Registrations

Patent applications and USPTO patent grants for Weeden; Timothy.The latest application filed is for "methods of preparing protein-oligonucleotide complexes".

Company Profile

0.6.19

Weeden; Timothy - Waltham MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Preparing Protein-oligonucleotide Complexes App 20220306685 - Weeden; Timothy ; et al.	2022-09-29
Muscle Targeting Complexes And Uses Thereof For Treating Dystrophinopathies App 20220288220 - Subramanian; Romesh R. ; et al.	2022-09-15
Methods of intravenouisly delivering anti-transferrin antibody/oligonucleotide complexes to subjects having muscular dystrophy Grant 11,390,682 - Subramanian , et al. July 19, 2	2022-07-19
Muscle targeting complexes and uses thereof for treating dystrophinopathies Grant 11,369,689 - Subramanian , et al. June 28, 2	2022-06-28
Muscle Targeting Complexes And Uses Thereof For Treating Facioscapulohumeral Muscular Dystrophy App 20220193250 - Subramanian; Romesh R. ; et al.	2022-06-23
Muscle Targeting Complexes And Uses Thereof For Treating Facioscapulohumeral Muscular Dystrophy App 20220169743 - Subramanian; Romesh R. ; et al.	2022-06-02
Muscle Targeting Complexes And Uses Thereof For Treating Dystrophinopathies App 20220143206 - Subramanian; Romesh R. ; et al.	2022-05-12
Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA Grant 11,286,305 - Subramanian , et al. March 29, 2	2022-03-29
Muscle targeting complexes and uses thereof for treating dystrophinopathies Grant 11,248,056 - Subramanian , et al. February 15, 2	2022-02-15
Muscle Targeting Complexes And Uses Thereof For Treating Dystrophinopathies App 20220025066 - Subramanian; Romesh R. ; et al.	2022-01-27
Muscle Targeting Complexes And Uses Thereof For Treating Facioscapulohumeral Muscular Dystrophy App 20210380709 - Subramanian; Romesh R. ; et al.	2021-12-09
Muscle targeting complexes and uses thereof for treating dystrophinopathies Grant 11,168,141 - Subramanian , et al. November 9, 2	2021-11-09
Muscle Targeting Complexes And Uses Thereof For Treating Centronuclear Myopathy App 20210322562 - Subramanian; Romesh R. ; et al.	2021-10-21
Muscle Targeting Complexes And Uses Thereof For Treating Fibrodysplasia Ossificans Progressiva App 20210322563 - Subramanian; Romesh R. ; et al.	2021-10-21
Muscle Targeting Complexes And Uses Thereof For Treating Hypertrophic Cardiomyopathy App 20210324101 - Subramanian; Romesh R. ; et al.	2021-10-21
Muscle Targeting Complexes And Uses Thereof For Treating Pompe Disease App 20210317226 - Subramanian; Romesh R. ; et al.	2021-10-14
Muscle Targeting Complexes And Uses Thereof For Treating Friedreich's Ataxia App 20210308274 - Subramanian; Romesh R. ; et al.	2021-10-07
Muscle Targeting Complexes And Uses Thereof For Treating Myotonic Dystrophy App 20210308272 - Subramanian; Romesh R. ; et al.	2021-10-07
Muscle Targeting Complexes And Uses Thereof For Treating Dystrophinopathies App 20210308273 - Subramanian; Romesh R. ; et al.	2021-10-07
Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4 Grant 11,111,309 - Subramanian , et al. September 7, 2	2021-09-07
Muscle-targeting Complexes And Uses Thereof App 20210261680 - Subramanian; Romesh R. ; et al.	2021-08-26
Muscle-targeting Complexes And Uses Thereof App 20210228730 - Subramanian; Romesh R. ; et al.	2021-07-29
Muscle Targeting Complexes And Uses Thereof For Treating Dystrophinopathies App 20210230290 - Subramanian; Romesh R. ; et al.	2021-07-29
Muscle Targeting Complexes And Uses Thereof For Treating Myotonic Dystrophy App 20210220479 - Subramanian; Romesh R. ; et al.	2021-07-22
Muscle Targeting Complexes And Uses Thereof For Treating Facioscapulohumeral Muscular Dystrophy App 20210206868 - Subramanian; Romesh R. ; et al.	2021-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.